Comparative single-cell transcriptomic profile of hybrid immunity induced by adenovirus vector-based COVID-19 … – Nature.com

Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384:40316.

Article CAS PubMed Google Scholar

Widge AT, Rouphael NG, Jackson LA, Anderson EJ, Roberts PC, Makhene M, et al. Durability of responses after SARS-CoV-2 mRNA-1273 vaccination. N Engl J Med. 2021;384:802.

Article CAS PubMed Google Scholar

Andreano E, Paciello I, Piccini G, Manganaro N, Pileri P, Hyseni I, et al. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants. Nature. 2021;600:5305.

Article CAS PubMed PubMed Central Google Scholar

Chen Y, Tong P, Whiteman N, Moghaddam AS, Zarghami M, Zuiani A, et al. Immune recall improves antibody durability and breadth to SARS-CoV-2 variants. Sci Immunol. 2022;7:eabp8328.

Article CAS PubMed Google Scholar

Stamatatos L, Czartoski J, Wan YH, Homad LJ, Rubin V, Glantz H, et al. mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection. Science. 2021;372:14138.

Article CAS PubMed PubMed Central Google Scholar

Reynolds CJ, Pade C, Gibbons JM, Butler DK, Otter AD, Menacho K, et al. Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose. Science. 2021;372:141823.

Article CAS PubMed PubMed Central Google Scholar

Wratil PR, Stern M, Priller A, Willmann A, Almanzar G, Vogel E, et al. Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. Nat Med. 2022;28:496503.

Article CAS PubMed Google Scholar

Gelanew T, Mulu A, Abebe M, Bates TA, Wassie L, Tefer M, et al. A single dose ChAdOx1 nCoV-19 vaccine elicits high antibody responses in individuals with prior SARS-CoV-2 infection comparable to that of double dose vaccinated SARS-CoV-2 infection naive individuals. Vaccines. 2022;10:859.

Guzman-Lopez S, Darwich-Salazar A, Bocanegra-Ibarias P, Salas-Trevino D, Flores-Trevino S, Perez-Alba E, et al. Clinical and immunologic efficacy of the recombinant adenovirus Type-5-Vectored (CanSino Bio) vaccine in university professors during the COVID-19 delta wave. Vaccines. 2022;10:656.

Article CAS PubMed PubMed Central Google Scholar

Cao Q, Wu S, Xiao C, Chen S, Chi X, Cui X, et al. Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization. Cell Discov. 2021;7:64.

Article CAS PubMed PubMed Central Google Scholar

Xiaojie S, Yu L, Lei Y, Guang Y, Min Q. Neutralizing antibodies targeting SARS-CoV-2 spike protein. Stem Cell Res. 2020;50:102125.

Article PubMed PubMed Central Google Scholar

Fagiani F, Catanzaro M, Lanni C. Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2. Signal Transduct Target Ther. 2020;5:170.

Article CAS PubMed PubMed Central Google Scholar

Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:357387.e29.

Article CAS PubMed PubMed Central Google Scholar

Borcherding N, Bormann NL, Kraus G. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Res. 2020;9:47.

Article CAS PubMed PubMed Central Google Scholar

Bewley KR, Coombes NS, Gagnon L, McInroy L, Baker N, Shaik I, et al. Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays. Nat Protoc. 2021;16:311440.

Article CAS PubMed Google Scholar

Melgoza-Gonzalez EA, Hinojosa-Trujillo D, Resendiz-Sandoval M, Mata-Haro V, Hernandez-Valenzuela S, Garcia-Vega M, et al. Analysis of IgG, IgA and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccines. Transbound Emerg Dis. 2022;69:e73445.

Article CAS PubMed Google Scholar

Bates TA, McBride SK, Leier HC, Guzman G, Lyski ZL, Schoen D, et al. Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Sci Immunol. 2022;7:eabn8014.

Article CAS PubMed Google Scholar

Hernndez J, Dehesa-Canseco F, Vzquez-Lpez AB, Resndiz-Sandoval M, Caire-Juvera G, Sols-Hernndez M, et al. Neutralization of Omicron BA.1, BA.5.1.6, BQ.1.3 and XBB1.1 induced by heterologous vaccination Ad5-nCoV and mRNA-1273. Signal Transduct Target Ther. 2023;8:174.

Article PubMed PubMed Central Google Scholar

Sherina N, Piralla A, Du L, Wan H, Kumagai-Braesch M, Andrll J, et al. Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection. Med. 2021;2:28195.e4.

Article CAS PubMed Google Scholar

Marcotte H, Piralla A, Zuo F, Du L, Cassaniti I, Wan H, et al. Immunity to SARS-CoV-2 up to 15 months after infection. iScience. 2022;25:103743.

Article CAS PubMed PubMed Central Google Scholar

He B, Liu S, Wang Y, Xu M, Cai W, Liu J, et al. Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq. Signal Transduct Target Ther. 2021;6:195.

Article CAS PubMed PubMed Central Google Scholar

Nie Y, Waite J, Brewer F, Sunshine MJ, Littman DR, Zou YR. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J Exp Med. 2004;200:114556.

Article CAS PubMed PubMed Central Google Scholar

Xiang H, Zhao Y, Li X, Liu P, Wang L, Wang M, et al. Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients. Hum Immunol. 2022;83:11929.

Article CAS PubMed Google Scholar

Yuan M, Wu NC, Zhu X, Lee CD, So RTY, Lv H, et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science. 2020;368:6303.

Article CAS PubMed PubMed Central Google Scholar

Liu H, Yuan M, Huang D, Bangaru S, Zhao F, Lee CD, et al. A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection. Cell Host Microbe. 2021;29:80618.e6.

Article CAS PubMed PubMed Central Google Scholar

Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31.

Article CAS PubMed PubMed Central Google Scholar

Kalia V, Sarkar S. Regulation of effector and memory CD8 T cell differentiation by IL-2-A balancing act. Front Immunol. 2018;9:2987.

Article CAS PubMed PubMed Central Google Scholar

Yeh N, Glosson NL, Wang N, Guindon L, McKinley C, Hamada H, et al. Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. J Immunol. 2010;185:208998.

Article CAS PubMed Google Scholar

Hamada H, de la Luz Garcia-Hernandez M, Reome JB, Misra SK, Strutt TM, McKinstry KK, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:346981.

Article CAS PubMed Google Scholar

Notarbartolo S, Ranzani V, Bandera A, Gruarin P, Bevilacqua V, Putignano AR, et al. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients. Sci Immunol. 2021;6:eabg5021.

Article PubMed Google Scholar

Continued here:

Comparative single-cell transcriptomic profile of hybrid immunity induced by adenovirus vector-based COVID-19 ... - Nature.com